PE-22-28 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

PE-22-28 is a synthetic research peptide studied in controlled laboratory environments for its involvement in neuroregulatory signalling pathways and receptor-interaction dynamics. This lyophilized 10 mg preparation is supplied in a sealed research vial and supports reproducible in vitro experimentation.

Peptide Overview

PE-22-28 has been incorporated into laboratory models investigating peptide-mediated neuronal communication and regulatory pathway modulation. Its defined molecular structure and stability profile make it suitable for comparative neuropeptide evaluation under tightly controlled experimental conditions.

Scientific Context

Research into short-chain regulatory peptides expanded significantly during the late twentieth and early twenty-first centuries as laboratories explored peptide-driven modulation of central signalling systems. PE-22-28 is utilised within this framework to study receptor-binding behaviour, intracellular cascade activation and neuroregulatory pathway modelling.

Mechanistic Focus in Research

• Neuroregulatory receptor interaction analysis
• Peptide-mediated signalling pathway modelling
• Intracellular cascade activation studies
• Comparative structure–function evaluation
• Controlled in vitro biochemical investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms validation for Batch GF102025052. Key analytical results include:

• Assay Content: 9.93 mg
• Identification – Retention Time: 0.998
• Identification – Spectrum: 999
• Purity: greater than 99.8 percent
• Endotoxin: detected but below 0.01 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures. Results relate only to the tested batch sample.

Research Applications

• Neuroregulatory pathway research
• Receptor-binding and signalling studies
• Peptide interaction modelling
• Comparative neuropeptide evaluation
• Controlled in vitro laboratory investigations

Grail Formula Quality

Every Grail Formula research peptide undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability and sealed-vial integrity. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment
• Supplied for human investigational use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 9.93 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin detected but below 0.01 EU per mg
No detectable microbial contamination
No detectable heavy metals
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.